目的:探讨影响IgA肾病患者预后的危险因素。方法:选取诊断为IgA肾病患者622例的基本资料,肾脏终点为患者肾小球过率(eGFR)下降50%或发生终末期肾病(ESRD)。采用Kaplan-Meier方法计算生存率,使用单因素及多因素COX回归分析影响IgA肾病患者预后的危险因素。结果:全部患者1年、3年、5年肾脏生存率分别为99.6%,98.4%,91.9%。多因素COX回归分析结果显示患者肾活检时慢性肾脏病(CKD)分期(HR:4.79,95%CI:1.25~18.36,P=0.022)、24 h尿蛋白定量(HR:5.08,95%CI:1.04~24.83,P=0.045)和血清补体C3(HR:0.01,95%CI:0.01~0.59,P=0.016)是IgA患者疾病进展的独立危险因素。结论:8.1%的IgA肾病患者在5年之内eGFR下降50%或进展为ESRD,肾活检时肾功能不全、高24 h尿蛋白定量以及低血清补体C3是预后的独立危险因素。
Objective: To identify the risk factors of poor outcome in patients with IgA nephropathy by retrospective cohort study. Methods: We enrolled 622 patients who were diagnosed as IgA nephropathy by renal biopsies and followed up regularly. All baseline clinical data were recorded and regular follow-up was performed. The survival rate was calculated by Kaplan-Meier method and risk factors were evaluated by univariate and multivariate COX proportional-hazards regression. Results: The 1-,3-and 5-year cumulative renal survival rate was 99. 6%,98. 4% and 91. 9% respectively. Multivariate COX analysis showed that CKD stages( HR: 4. 79,95% CI: 1. 25-18. 36,P = 0. 022),24 h protein excretion( HR: 5. 08,95% CI: 1. 04-24. 83,P = 0. 045) and serum C3( HR: 0. 01,95% CI: 0. 010. 59,P = 0. 016) were significantly independent risk factors. Conclusion: 8. 1% patients of IgA nephropathy have 50% decrease in eGFR or progress to end stage renal disease within 5 years. Three clinical features-impaired renal function,higher proteinuria and lower serum C3-are independent predictors of poor outcome in patients with IgA nephropathy.